Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform

Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform

US Patent 8771953 · Granted Jul 8, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNA editing as biomarkers for mood disorders test2024
RNA editing as biomarkers for mood disorders test2024
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2024
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2024
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2024
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2024
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2020
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2020
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2020
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2020
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2019
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activiti2019